Article
High MBL-expressing genotypes are associated with deterioration in renal function in type 2 diabetes.
Frontiers in immunology - 1 Jan 2022
Dørflinger G H, Høyem P H, Laugesen E, Østergaard J A, Funck K L, Steffensen R, Poulsen P L, Hansen T K, Bjerre M
Abstract excerpt
Introduction: Accumulating evidence support that mannan-binding lectin (MBL) is a promising prognostic biomarker for risk-stratification of diabetic micro- and macrovascular complications. Serum MBL levels are predominately genetically determined and depend on MBL genotype. However, Type 1 diabetes (T1D) is associated with higher MBL serum levels for a given MBL genotype, but it remains unknown if this is also...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
